Eli Lilly agreed to acquire AtaiBeckley for up to $3.8 billion—of which Lilly will pay $2.8 billion upfront. The deal, set to ...

A study in mice and in human cells by Stanford Medicine researchers has linked organ aging to the increased inabilityw ...

The enzyme binding domains made with this AI strategy were less similar to closely-related natural proteins than those from ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

The team’s strategy—called antibody–ADC click—relies on the rapid ligation between trans‑cyclooctene (TCO) and tetrazine ...

The researchers have made the data from the study accessible to medical researchers worldwide through an open access platform ...

Researchers uncover how tick‑borne nairoviruses strip immune‑signaling tags, offering a path toward biosurveillance as new ...

Approximately three million people worldwide struggle with chronic pancreatitis, for which there is no cure. In a study ...

Ketogenic diets, originally developed in the 1920s to treat epilepsy, have been adapted in the past few decades as a strategy ...

Genome-scale CRISPRi mapping reveals how gene perturbations reshape human iPSC transcriptomes, surfacing regulators of ...

Harvard Medical School researchers have uncovered how viruses hijack cells’ garbage-disposal systems to evade immune attack.